Campaign to distribute 50,000 self-adjustable glasses to children in need
Friday, 17 February 2017
100 million children in the developing world sit in classrooms without being able to see the blackboard clearly. In a bid to help combat this shocking statistic, ChildVision is launching a crowdfunding campaign to distribute their innovative, self-adjustable glasses to those who need them most.
Poor vision has a significant impact on the education, quality of life, and economic potential of young people. Professor Joshua Silver created the first self-adjustable glasses, the Adspecs, an invention that led to his nomination as ‘Inventor of the Year’ in 2011 by the European Patent Office.
The glasses are based on a fluid-filled lens technology that the user adjusts until they can see clearly. While Adspecs were designed for adult use, ChildVision glasses use similar technology but the glasses have been developed specifically for young people aged between 12 and 18.
Professor Silver explains, ‘Have you ever thought about what it would be like to need eyeglasses and not have them? Or to live in a part of the world where there are no opticians? At present, there are approximately 100 million teenagers suffering from myopia, or near-sightedness and we hope our glasses will make a substantial difference to their lives.’
Aesthetics are very important, particularly among teenagers. With that in mind, the ChildVision frames are small, light and attractive and have been designed to withstand challenging environments.
The ChildVision team is hoping to raise £800,000 on the crowdfunding website Indiegogo and aims to distribute up to 50,000 pairs of these glasses to children in schools across Africa, Asia and Latin America.
Professor Silver continues: ‘Poor vision is one of the world's largest international development challenges. We are very excited to be working with our friends at Indiegogo in a campaign to help children get the most out of their education and to build a brighter future, not only for them but their communities.’
Published clinical trials have been carried out to demonstrate the glasses’ effectiveness. These papers can be read here: